William R. Crom - Concepedia

Author

William R. Crom

St. Jude Children's Research Hospital

Also Known As

W R Crom, William R Crom, William R. Crom

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

St. Jude Children's Research Hospital University of Tennessee Health Science Center University of Tennessee at Knoxville American Association of Colleges of Pharmacy University of Arkansas for Medical Sciences

About

William R. Crom is an author at St. Jude Children's Research Hospital specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	847
2	Health Sciences	2	2	85
3	Allergy	1	1	56
4	Biochemistry	1	1	20
5	Biostatistics	1	1	33

William R. Crom

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Conventional Compared with Individualized Chemotherapy for Childhood Acute Lymphoblastic Leukemia William E. Evans, Mary V. Relling, John H. Rodman, New England Journal of Medicine	1998	495
Cerebrospinal fluid pharmacokinetics and penetration of continuous infusion topotecan in children with central nervous system tumors Sharyn D. Baker, Richard L. Heideman, William R. Crom, Cancer Chemotherapy and Pharmacology Neuro-oncologyPediatric Brain TumorsCerebrospinal FluidContinuous Infusion TopotecanIntracranial Pressure	1995	138
Pharmacokinetics of vincristine in children and adolescents with acute lymphocytic leukemia William R. Crom, Siebold S.N. de Graaf, Timothy W. Synold, The Journal of Pediatrics Hematological MalignancyMedicineHematologyPharmacologyPharmacotherapy	1994	120
Anaphylactoid reactions to escherichia coli and erwinia asparaginase in children with leukemia and lymphoma William E. Evans, Anastasios A. Tsiatis, Gaston K. Rivera, Cancer	1982	112
Pharmacokinetics and toxicity of methotrexate in children with Down syndrome and acute lymphocytic leukemia Maria Luisa Garrè, Mary V. Relling, David K. Kalwinsky, The Journal of Pediatrics Down SyndromeHematological MalignancyOncologyPediatric HematologyMedicine	1987	99
Dextromethorphan and caffeine as probes for simultaneous determination of debrisoquin-oxidation and N-acetylation phenotypes in children William E. Evans, Mary V. Relling, William P. Petros, Clinical Pharmacology & Therapeutics	1989	96
Removal of methotrexate, leucovorin, and their metabolites by combined hemodialysis and hemoperfusion Mary V. Relling, F. Bruder Stapleton, Judith Ochs, Cancer	1988	82
Methotrexate bioavailability after oral and intramuscular administration in children M. Teresi, William R. Crom, Kyung Eob Choi, The Journal of Pediatrics Methotrexate BioavailabilityPediatricsOral MedicinePharmacotherapyMedicine	1987	77
Methotrexate cerebrospinal fluid and serum concentrations after intermediate-dose methotrexate infusion William E. Evans, Paul R. Hutson, Clinton F. Stewart, Clinical Pharmacology & Therapeutics	1983	76
Disposition of irinotecan and SN-38 following oral and intravenous irinotecan dosing in mice Clinton F. Stewart, William C. Zamboni, William R. Crom, Cancer Chemotherapy and Pharmacology AllergyPharmacological StudyMedicineToxicologyPharmacotherapy	1997	56

Page 1